
ArriVent BioPharma Reports 2024 Financial Results and Key Achievements
NEWTOWN SQUARE, PA — ArriVent BioPharma, Inc. (NASDAQ: AVBP) announced its 2024 financial results, showcasing significant progress in clinical programs and pipeline expansion. The company highlighted substantial milestones achieved over …
ArriVent BioPharma Reports 2024 Financial Results and Key Achievements Read More